Law360 Publishes Keith Hasson Article Discussing New Bulk Substance Rules Impact

Keith Hasson authored an article published by Law360 on March 28, 2017, discussing the ongoing regulatory updates compounding pharmacies must monitor, including changes in the U.S. Food and Drug Administration (FDA) inspection…

Continue ReadingLaw360 Publishes Keith Hasson Article Discussing New Bulk Substance Rules Impact

What compounding pharmacies need to know about USP 795 guidelines on nonsterile drug preparations

Nonsterile drug compounding, which refers to formulating medications that patients drink, swallow or apply to the skin, is the most common kind of drug compounding done in community and hospital…

Continue ReadingWhat compounding pharmacies need to know about USP 795 guidelines on nonsterile drug preparations

FDA pharmacy committee approves 2 substances for compounded medications, rejects 3 others

Two bulk substances that can treat warts and skin discoloration have been approved for use in compounded medications in a meeting of the U.S. Food and Drug Administration’s Pharmacy Compounding…

Continue ReadingFDA pharmacy committee approves 2 substances for compounded medications, rejects 3 others

These insanitary conditions are FDA’s red flags for compounding pharmacies

Insanitary conditions in compounding pharmacies can lead to tragedy. The 2012 outbreak of fungal meningitis, which killed more than 60 people and was caused by contaminated steroids, illustrates the seriousness…

Continue ReadingThese insanitary conditions are FDA’s red flags for compounding pharmacies